Conclusions: Aortic neck diameter increases consistently over time following EVAR. The degree of neck dilatation correlates with degree of device oversize but not with device type.
Summary: Implications of aortic neck dilatation following endovascular aneurysm repair (EVAR) are unclear. Previous studies are limited to comparisons of individual, early generation devices. The authors' compared aortic neck dilatation among contemporary stent grafts in this retrospective study of a prospectively maintained single center database. They reviewed preoperative and postoperative computed tomographic angiograms (at least one > 6 months after implant) for elective EVARs performed from [2008] [2009] [2010] [2011] [2012] [2013] [2014] . Images were analyzed using three-dimensional centerline reconstructions. Aortic neck diameter was measured in orthogonal planes at and 10mm below the lowest renal artery. Device type and main body graft diameter were obtained from operative reports. Eighty-six patients were analyzed with a median radiologic follow-up of 21.9 months (range, 4-64 months) and 81.3% had imaging at one year. The cohort was predominantly male (86.1%) with a mean age of 75.6 years (range, 60-94 years) and comorbidities were notable for significant coronary disease (50.0%) and smoking history (76.7%). Stent grants implanted included 26 Cook Zenith, 26 Gore Excluder, 22 Medtronic Endurant, 10 Endologix Powerlink, and 2 Trivascular Ovation devices. Mean device oversizing was 13.6 6 11.5% and did not vary by device type (P ¼ .54). Most patients (86.0%) experienced increases in aortic neck diameter during follow-up, with a mean increase of 1.3 6 2.2 mm (5.9 6 9.3 %) and 3.3 6 0.6 mm (8.9 6 2.5%) at 30 day and at latest follow-up scans, respectively. Repeated-measures analysis further demonstrated a significant increase in mean neck dilatation during follow-up (P < .001). Neck dilatation was not significantly different across different devices (P ¼ .233). However, there was a moderate positive correlation between percent change in neck diameter and degree of oversizing, which was statistically significant (P < .001). Type IA endoleak was observed in two patients and was associated with greater mean neck dilatation (8.8 6 3.3 mm vs 3.35 6 2.71; P ¼ .041). There was no relationship between changes in neck diameter and sac regression/expansion.
Comments: This study demonstrates infrarenal aortic neck dilation after endograft repair, which is progressive over time and associated with endograft oversizing. Whether this is due to the radial force the device uses to secure water tight seal, which then ceases when this force vector reaches equilibrium as some studies suggest, or to progressive aneurysmal growth is still not completely understood. The latter event would, of course, be unfortunate since a wave of type IA endoleaks would be expected that fortunately has not be observed in current experience. This study would confirm this lack of clinical consequence but lacks longterm follow-up. A similar focus was reported in the Journal of Vascular Surgery but at 24 months there was a negative clinical impact with a higher risk of type IA endoleaks observed at 24 months. 1 Much is yet to be learned regarding endograft repair of infrarenal abdominal aortic aneurysms in the long-term that being 10-15 years. Summary: Real-world contemporary date on trends in rates and outcomes of carotid endarterectomy and carotid artery stenting are limited. The goal of this study is to describe US national trends in performance and outcomes of isolated carotid endarterectomy or stenting among Medicare beneficiaries from 1999 to 2014 (16 years) and was accomplished by serial cross-sectional analysis of Medicare fee-for-service beneficiaries aged 65 years or older using the Medicare Inpatient and Denominator files. Spatial mixed models adjusted for age, sex, and race were fit to calculate county-specific risk-standardized revascularization rates. Mixed models were fit to assess trends in outcomes after adjustment for demographics, comorbidities, and symptomatic status. The major outcomes were revascularization rates per 100 000 beneficiaryyears of fee-for-service enrollment, in-hospital mortality, 30-day stroke or death, 30-day stroke, myocardial infarction, or death, 30-day all-cause mortality, and 1-year stroke. During the study; 937,111 unique patients underwent carotid endarterectomy (mean age, 75.8 years; 43% women) and 231,077 underwent carotid artery stenting (mean age, 75.4 years; 49% women). There were 81,306 patients who underwent endarterectomy in 1999 and 36,325 in 2014; national rates per 100 000 beneficiaryyears decreased from 298 in 1999-2000 to 128 in 2013-2014 (P < .001). The number of patients who underwent stenting ranged from 10,416 in 1999 to 22,865 in 2006 (an increase per 100 000 beneficiary-years from 40 in 1999-2000 to 75 in 2005-2006; P < 0.001); by 2014, there were 10,208 patients who underwent stenting and the rate decreased to 38 per 100,000 beneficiary-years (P < .001). County specific variations were noted with higher rates for both procedures in central and southern regions that did not change over time. For both procedures, there was an increase in the proportion of symptomatic patients over time (P < .001). For example in those undergoing a carotid artery stenting, the percentage of symptomatic patients varied from 14.4% in 1999-2000 to 25.9% in 2013-2014. Outcomes improved over time despite increases in vascular risk factors (all factors: P < .001). The composite of ischemic stroke or death decreased from 4.4% in 1999-2000 to 3.1% in 2013-2014 for carotid endarterectomy and from 7.0% to 4.8% between 1999-2000 and 2005-2006 and then increased to 7.0% by 2013-2014 for carotid artery stenting. There were adjusted annual decreases in 30-day ischemic stroke or death of 2.90% (95% confidence interval [CI], 2.63%-3.18%) among patients who underwent endarterectomy and 1.13% (95% CI, 0.71%-1.54%) among patients who underwent stenting; an absolute decrease from 1999 to 2014 was observed for endarterectomy (1.4%; 95% CI, 1.2%-1.5%) but not stenting (À0.1%; 95% CI, À 0.5% to 0.4%). Rates for 1-year ischemic stroke decreased after endarterectomy (absolute decrease, 3.5%; 95% CI, 3.2%-3.7%; adjusted annual decrease, 2.17%; 95% CI, 2.00%-2.34%) and stenting (absolute decrease, 1.6%; 95% CI, 1.2%-2.1%; adjusted annual decrease, 1.86%; 95% CI, 1.45%-2.26%). Additional improvements were noted for in-hospital mortality, 30-day stroke, myocardial infarction, or death, and 30-day all-cause mortality as well as within demographic subgroups. The index median hospital stay decreased from 2 to 1 day for each procedure while cost decreased for carotid endarterectomy to $6779 while that for carotid artery stenting increased to $14796.
Comments: The scrutiny of carotid procedures has been evident since the early 1980's and has continued/intensified since that time while the medical management of atherosclerosis has improved both likely leading to improvements in interventional results. The decrease in carotid artery stenting procedures reflects a restriction to reimbursement in the Medicare population. Interestingly, there are still a high percentage of asymptomatic patients undergoing carotid artery stenting during a time when reimbursement outside of a study is curtailed. In the final analysis, this "big data" study confirms that carotid artery stenting has higher 30-day risks and cost, which likely influences decisions made by Medicare regarding reimbursement.
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